Abstract
Background
Surgical resection alone does not cure the majority of patients with retroperitoneal sarcoma (RPS). We evaluated the effects of preoperative external-beam radiotherapy (XRT) and postoperative brachytherapy (BT) combined with complete surgical resection.
Methods
Fifty-five patients with primary or locally recurrent RPS judged to be resectable were entered onto a trial of combined therapy and observed prospectively. Forty-six patients underwent complete gross resection with curative intent. Of these, 41 patients completed preoperative XRT and 23 patients received BT. Outcome measures were treatment toxicity, overall survival, and disease-free survival (DFS).
Results
Preoperative XRT was very well tolerated and was associated with Radiation Therapy Oncology Group acute toxicity scores of ≤2 in all patients. Acute postoperative and BT-related toxicity resulted in modified RTOG scores of ≥3 in 39.1% (18 of 46) of patients. Late toxicity was associated with death in 4.3% (2 of 46) and with life-threatening illness in 2.2% (1 of 46) of patients, all of whom had been treated with BT to the upper abdomen. The 2-year overall survival and DFS for resected RPS were 88% and 80%, respectively. Significantly better 2-year DFS was achieved in patients with primary RPS and in those with low-grade tumors (93% and 95%, respectively).
Conclusions
The initial results of combined therapy are promising. Although preoperative XRT was very well tolerated, BT to the upper abdomen was associated with substantial toxicity. Our current protocol includes selective application of BT to the lower abdomen only.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvarenga JC, Ball ABS, Fisher C, et al. Limitations of surgery in the treatment of retroperitoneal sarcoma.Br J Surg 1991;78:912–6.
Bevilacqua RG, Rogatko A, Hafdu SI, Brennan MF. Prognostic factors in primary retroperitoneal soft-tissue sarcomas.Arch Surg 1991;26:328–34.
Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft tissue sarcoma. Analysis of 500 patients treated and followed at a single institution.Ann Surg 1998;228:355–65.
Dalton R, Donohue JG, Mucha PJ, et al. Management of retroperitoneal sarcomas.Surgery 1989;106:725–32; discussion, 732–3.
Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum.Ann Surg 1990;212:51–9.
McGrath PC, Neifeld JP, Lawrence W, et al. Improved survival following complete excision of retroperitoneal sarcomas.Ann Surg 1984;200:200–4.
van Doorn RC, Gallee PW, Hart AA, et al. Resectable retroperitoneal soft tissue sarcomas.Cancer 1994;73:637–42.
Catton CN, O’Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma.Int J Radiat Oncol Biol Phys 1994;29:1005–10.
Sugarbaker P. Patterns of spread of recurrent intraabdominal sarcoma.Cancer Treat Res 1996;82:65–77.
Storm FK, Eilber FR, Mirra J, Morton DL. Retroperitoneal sarcomas: a reappraisal of treatment.J Surg Oncol 1981;17:1–7.
Sindelar WF, Hoekstra HJ, Kinsella TJ. Surgical approaches and techniques in intraoperative radiotherapy for intra-abdominal, retroperitoneal and pelvic neoplasms.Surgery 1988;103:247–56.
Pisters PWT. Chemoradiation treatment strategies for localized sarcoma: conventional and investigational approaches.Semin Surg Oncol 1999;17:66–71.
Catton CN, Swallow CJ, O’Sullivan B, et al. A pilot study of external beam radiotherapy and pulsed dose rate brachytherapy for resectable retroperitoneal sarcomas (abstract).Radiother Oncol 1998;47(Suppl):S30.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.
Heslin JF, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcomas: implications for management.J Clin Oncol 1997;15:2832–9.
Tepper JE, Suit HD, Wood WC, et al. Radiation therapy of retroperitoneal soft tissue sarcomas.Int J Radiat Oncol Biol Phys 1984;10:825–30.
Fein DA, Corn BW, Lanciano RM, et al. Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control?.Int J Radiat Oncol Biol Phys 1995;31:129–34.
Glenn J, Sindelar WF, Kinsella T, et al. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum.Surgery 1985;97:316–24.
Levay J, O’Sullivan B, Catton CN, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult.Int J Radiat Oncol Biol Phys 1993;27:1091–9.
Jenkins MP, Alvarenga JC, Thomas JM. The management of retroperitoneal soft tissue sarcomas.Eur J Cancer 1996;32A:622–6.
Kilkenny JW III, Bland KI, Copeland EM III. Retroperitoneal sarcoma: the University of Florida experience.J Am Coll Surg 1996;182:329–39.
Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.Ann Surg 1995;221:185–95.
Karakousis CP, Gertsenbluth R, Kontzoglou K, Driscoll DL. Retroperitoneal sarcomas and their management.Arch Surg 1995;130: 1104–9.
Hendricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.Am J Surg Pathol 1997;21:271–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jones, J.J., Catton, C.N., O’Sullivan, B. et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Annals of Surgical Oncology 9, 346–354 (2002). https://doi.org/10.1007/BF02573869
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02573869